Home World News Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with... World News Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity By Ogkologos - December 2, 2024 1038 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Young Breast Cancer Survivor Killed in Hit and Run Crash Weeks... August 25, 2021 Many Men with Penile Cancer Do Not Get Recommended Treatments, Study... March 22, 2018 Why people and culture matter in research August 10, 2021 Ovarian cancer screening trial did not save lives May 12, 2021 Load more HOT NEWS Adding Pembrolizumab to Docetaxel Does Not Significantly Improve Outcomes in Patients... FDA Approves Liquid Biopsy NGS Companion Diagnostic Test for Multiple Cancers... Cancer Survivor with Strong Family History Was Denied Regular Screening Because... Cancer target missed for 55,000 patients over 6 years
